HSPA6
Basic information
Region (hg38): 1:161524540-161526894
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the HSPA6 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 48 | 49 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 48 | 4 | 1 |
Variants in HSPA6
This is a list of pathogenic ClinVar variants found in the HSPA6 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-161524687-G-C | not specified | Uncertain significance (Jul 16, 2024) | ||
1-161524696-T-C | not specified | Uncertain significance (Mar 04, 2024) | ||
1-161524701-A-G | not specified | Uncertain significance (Aug 11, 2022) | ||
1-161524768-A-G | not specified | Uncertain significance (Oct 26, 2022) | ||
1-161524770-C-A | not specified | Uncertain significance (Nov 08, 2022) | ||
1-161524779-C-A | not specified | Uncertain significance (Apr 05, 2023) | ||
1-161524805-C-G | Likely benign (Oct 01, 2022) | |||
1-161524863-G-A | not specified | Uncertain significance (Jul 02, 2024) | ||
1-161524882-T-G | not specified | Uncertain significance (Jun 22, 2023) | ||
1-161524912-T-C | not specified | Uncertain significance (Jun 26, 2023) | ||
1-161524932-T-G | not specified | Uncertain significance (Dec 03, 2024) | ||
1-161524935-C-A | not specified | Uncertain significance (Nov 03, 2022) | ||
1-161524936-C-A | not specified | Uncertain significance (Aug 12, 2024) | ||
1-161524971-G-T | not specified | Uncertain significance (Feb 14, 2023) | ||
1-161524986-C-A | not specified | Uncertain significance (Apr 07, 2022) | ||
1-161524995-G-A | not specified | Uncertain significance (Jan 23, 2023) | ||
1-161525002-C-G | not specified | Uncertain significance (Jul 28, 2021) | ||
1-161525010-C-G | not specified | Uncertain significance (Sep 13, 2023) | ||
1-161525127-C-A | not specified | Uncertain significance (Feb 26, 2024) | ||
1-161525185-A-G | not specified | Uncertain significance (Jan 24, 2024) | ||
1-161525212-A-G | not specified | Uncertain significance (Sep 18, 2024) | ||
1-161525250-C-T | Benign (Apr 28, 2020) | |||
1-161525262-C-G | not specified | Uncertain significance (Nov 17, 2022) | ||
1-161525306-T-C | Likely benign (Dec 01, 2022) | |||
1-161525313-T-G | not specified | Uncertain significance (Jan 03, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
HSPA6 | protein_coding | protein_coding | ENST00000309758 | 1 | 2646 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00000683 | 0.493 | 0 | 0 | 0 | 0 | 0.00 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.217 | 398 | 386 | 1.03 | 0.0000221 | 4169 |
Missense in Polyphen | 163 | 166.14 | 0.98107 | 1894 | ||
Synonymous | -0.280 | 173 | 168 | 1.03 | 0.00000973 | 1348 |
Loss of Function | 0.639 | 9 | 11.3 | 0.795 | 4.80e-7 | 158 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Molecular chaperone implicated in a wide variety of cellular processes, including protection of the proteome from stress, folding and transport of newly synthesized polypeptides, activation of proteolysis of misfolded proteins and the formation and dissociation of protein complexes. Plays a pivotal role in the protein quality control system, ensuring the correct folding of proteins, the re-folding of misfolded proteins and controlling the targeting of proteins for subsequent degradation. This is achieved through cycles of ATP binding, ATP hydrolysis and ADP release, mediated by co-chaperones. The affinity for polypeptides is regulated by its nucleotide bound state. In the ATP-bound form, it has a low affinity for substrate proteins. However, upon hydrolysis of the ATP to ADP, it undergoes a conformational change that increases its affinity for substrate proteins. It goes through repeated cycles of ATP hydrolysis and nucleotide exchange, which permits cycles of substrate binding and release (PubMed:26865365). {ECO:0000303|PubMed:26865365}.;
- Pathway
- Antigen processing and presentation - Homo sapiens (human);Legionellosis - Homo sapiens (human);Endocytosis - Homo sapiens (human);Longevity regulating pathway - multiple species - Homo sapiens (human);Influenza A - Homo sapiens (human);Protein processing in endoplasmic reticulum - Homo sapiens (human);Estrogen signaling pathway - Homo sapiens (human);MAPK signaling pathway - Homo sapiens (human);Toxoplasmosis - Homo sapiens (human);Spliceosome - Homo sapiens (human);Measles - Homo sapiens (human);Epstein-Barr virus infection - Homo sapiens (human);Parkin-Ubiquitin Proteasomal System pathway;Cellular response to heat stress;MAPK Signaling Pathway;Neutrophil degranulation;HSF1 activation;Attenuation phase;HSF1-dependent transactivation;Regulation of HSF1-mediated heat shock response;Cellular responses to stress;Innate Immune System;Immune System;Cellular responses to external stimuli;Cellular response to heat stress
(Consensus)
Intolerance Scores
- loftool
- rvis_EVS
- -0.02
- rvis_percentile_EVS
- 52.25
Haploinsufficiency Scores
- pHI
- 0.192
- hipred
- N
- hipred_score
- 0.418
- ghis
- 0.452
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.861
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- response to unfolded protein;cellular response to heat;cellular response to unfolded protein;protein refolding;neutrophil degranulation;chaperone cofactor-dependent protein refolding;cellular heat acclimation
- Cellular component
- extracellular region;nucleus;cytoplasm;centriole;cytosol;COP9 signalosome;protein-containing complex;secretory granule lumen;extracellular exosome;blood microparticle;ficolin-1-rich granule lumen
- Molecular function
- protein binding;ATP binding;ATPase activity;enzyme binding;heat shock protein binding;ATPase activity, coupled;protein folding chaperone;unfolded protein binding;misfolded protein binding